NYLIM
AXGN icon

New York Life Investment Management’s Axogen AXGN Stock Holding History

New York Life Investment Management’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-71,445
Closed -$713K – 1215
2022
Q4 		$713K Buy
71,445
+7,665
+12% +$85.1K 0.01% 671
2022
Q3 		$760K Buy
63,780
+5,047
+9% +$50.5K 0.01% 643
2022
Q2 		$481K Buy
+58,733
New +$502K 0.01% 747

Other funds holding AXGN

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

New York Life Investment Management's AXGN Position: Q1 2023 in Review

New York Life Investment Management sold out of Axogen (AXGN) in Q1 2023, closing a stake of 71,445 shares — an estimated $713K sold.

New York Life Investment Management first reported a position in AXGN in Q2 2022 and held it in 3 quarters. The position peaked at $760K in Q3 2022. 130 funds tracked by Wall St. Rank hold AXGN as of Q1 2023.

  • New York Life Investment Management reported no remaining Axogen position as of Q1 2023 after selling out during the quarter.
  • New York Life Investment Management sold 71,445 Axogen shares in Q1 2023, an estimated $713K.
  • New York Life Investment Management first reported a position in Axogen in Q2 2022 and held it in 3 quarters.
  • New York Life Investment Management's Axogen position peaked at $760K in Q3 2022.
  • 130 funds tracked by Wall St. Rank held Axogen as of Q1 2023.

Based on New York Life Investment Management's 13F filing for Q1 2023, filed 8 May 2023.